We bring you this week’s healthcare and medtech trends, in Boston and beyond:
This was a big week for Maxwell Health, a Boston-based health service platform that recently announced it had raised $26.4 million. The money, which came from a variety of investors including Cambia Health Solutions and Tribeca Venture Partners, brings Maxwell’s total funding to $34.4 million. They also announced a partnership with MetLife Insurance with the ultimate goal of providing insurance policies and products that go beyond traditional employer-based options. Given Maxwell Health’s track record of partnering with unorthodox health services and making an app that includes a virtual insurance ID card, the new funding and partnership could lead to a tech-related disruption in health insurance.
The College of Radiology (ACR) and Massachusetts General Hospital (MGH) are among the first organizations to begin using Nuance’s new PowerShare Innovation Program. Participating organizations can share clinical guidelines to the radiologist’s workflow, while the program automates the process of collecting and reporting quality measures to meet industry guidelines. This also gives ACR and MGH access to data that could be used to create applications from the images and reports generated by the program.
This Wednesday and Thursday, Forbes held their annual Healthcare Summit. The conference featured a wide array of speakers, ranging from Luciana Borio, Assistant Commissioner for Counterterrorism Policy at the FDA, to Celgene CEO Bob Hugin. This year, the focus of the conference was “Smart Data Transforming Lives,” or how better information can be used to save money— and lives. Many speakers at the conference stressed the importance of EHRs in the future of healthcare, such as Eric Shadt, who claimed that “5 or 10 years from now there’s going to be more info about your health outside the medical center than inside.” But those at the summit were not blind to the potential roadblocks that EHRs face; according to a report released at the summit, 80% of patients worry about the security of their health data, and patients are especially wary about making their health information available electronically.
Brendan Pease was MedTech Boston's first ever editorial and events intern. He is now a junior at Harvard University where he studies Molecular and Cellular Biology. He’s also the Co-Editor-in-Chief for the Harvard Science Review. Previously, he worked as a Market Intelligence intern at athenahealth and as a research assistant in the Goldberg Laboratory at Massachusetts General Hospital.
Send this to a friend